BMRN logo

BioMarin Pharmaceutical (BMRN) Current liabilities

annual current liabilities:

$606.99M-$570.04M(-48.43%)
December 31, 2024

Summary

  • As of today (July 1, 2025), BMRN annual total current liabilities is $606.99 million, with the most recent change of -$570.04 million (-48.43%) on December 31, 2024.
  • During the last 3 years, BMRN annual current liabilities has risen by +$60.49 million (+11.07%).
  • BMRN annual current liabilities is now -48.43% below its all-time high of $1.18 billion, reached on December 31, 2023.

Performance

BMRN Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

quarterly current liabilities:

$628.21M+$21.23M(+3.50%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN quarterly total current liabilities is $628.21 million, with the most recent change of +$21.23 million (+3.50%) on March 31, 2025.
  • Over the past year, BMRN quarterly current liabilities has dropped by -$459.69 million (-42.25%).
  • BMRN quarterly current liabilities is now -46.63% below its all-time high of $1.18 billion, reached on December 31, 2023.

Performance

BMRN quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

BMRN Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-48.4%-42.3%
3 y3 years+11.1%+28.1%
5 y5 years-34.9%-23.4%

BMRN Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-48.4%+11.1%-46.6%+35.2%
5 y5-year-48.4%+23.2%-46.6%+46.1%
alltimeall time-48.4%>+9999.0%-46.6%>+9999.0%

BMRN Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$628.21M(+3.5%)
Dec 2024
$606.99M(-48.4%)
$606.99M(-15.2%)
Sep 2024
-
$715.66M(-32.9%)
Jun 2024
-
$1.07B(-1.9%)
Mar 2024
-
$1.09B(-7.6%)
Dec 2023
$1.18B(+99.9%)
$1.18B(+1.2%)
Sep 2023
-
$1.16B(+94.8%)
Jun 2023
-
$597.23M(-0.2%)
Mar 2023
-
$598.23M(+1.6%)
Dec 2022
$588.88M(+7.8%)
$588.88M(+13.0%)
Sep 2022
-
$521.02M(+12.1%)
Jun 2022
-
$464.73M(-5.2%)
Mar 2022
-
$490.42M(-10.3%)
Dec 2021
$546.50M(+11.0%)
$546.50M(+6.1%)
Sep 2021
-
$514.90M(+16.1%)
Jun 2021
-
$443.34M(+3.1%)
Mar 2021
-
$430.04M(-12.7%)
Dec 2020
$492.55M(-47.2%)
$492.55M(-42.4%)
Sep 2020
-
$854.69M(+5.1%)
Jun 2020
-
$813.30M(-0.9%)
Mar 2020
-
$820.47M(-12.0%)
Dec 2019
$932.50M(+78.2%)
$932.50M(+88.9%)
Sep 2019
-
$493.75M(+12.4%)
Jun 2019
-
$439.43M(-12.3%)
Mar 2019
-
$500.99M(-4.3%)
Dec 2018
$523.24M(-35.9%)
$523.24M(-37.6%)
Sep 2018
-
$838.66M(+4.2%)
Jun 2018
-
$804.95M(+4.1%)
Mar 2018
-
$773.47M(-5.3%)
Dec 2017
$816.52M(+85.9%)
$816.52M(+95.6%)
Sep 2017
-
$417.53M(+11.5%)
Jun 2017
-
$374.30M(+10.0%)
Mar 2017
-
$340.21M(-22.6%)
Dec 2016
$439.31M(-1.4%)
$439.31M(+16.4%)
Sep 2016
-
$377.33M(+3.5%)
Jun 2016
-
$364.58M(-6.0%)
Mar 2016
-
$388.01M(-12.9%)
Dec 2015
$445.46M(+89.0%)
$445.46M(+14.1%)
Sep 2015
-
$390.49M(+12.3%)
Jun 2015
-
$347.70M(+13.8%)
Mar 2015
-
$305.51M(+29.6%)
Dec 2014
$235.74M(+28.6%)
$235.74M(+14.1%)
Sep 2014
-
$206.55M(+23.9%)
Jun 2014
-
$166.72M(+6.8%)
Mar 2014
-
$156.04M(-14.9%)
Dec 2013
$183.27M(+7.5%)
$183.27M(+9.3%)
Sep 2013
-
$167.63M(+17.9%)
Jun 2013
-
$142.24M(-1.2%)
Mar 2013
-
$144.01M(-15.5%)
Dec 2012
$170.43M(+81.1%)
$170.43M(+26.3%)
Sep 2012
-
$134.93M(+12.4%)
Jun 2012
-
$120.00M(+0.2%)
Mar 2012
-
$119.81M(+27.3%)
DateAnnualQuarterly
Dec 2011
$94.13M(+12.3%)
$94.13M(+13.1%)
Sep 2011
-
$83.25M(+1.5%)
Jun 2011
-
$82.03M(+8.0%)
Mar 2011
-
$75.99M(-9.4%)
Dec 2010
$83.84M(+7.3%)
$83.84M(-9.0%)
Sep 2010
-
$92.10M(+9.7%)
Jun 2010
-
$83.93M(+6.6%)
Mar 2010
-
$78.70M(+0.7%)
Dec 2009
$78.15M(-39.9%)
$78.15M(+22.0%)
Sep 2009
-
$64.07M(+6.7%)
Jun 2009
-
$60.03M(-52.5%)
Mar 2009
-
$126.31M(-2.9%)
Dec 2008
$130.08M(+111.4%)
$130.08M(+7.7%)
Sep 2008
-
$120.73M(+90.4%)
Jun 2008
-
$63.42M(+19.0%)
Mar 2008
-
$53.31M(-13.4%)
Dec 2007
$61.54M(+33.7%)
$61.54M(+25.4%)
Sep 2007
-
$49.06M(+10.1%)
Jun 2007
-
$44.54M(+14.7%)
Mar 2007
-
$38.83M(-15.7%)
Dec 2006
$46.05M(+14.1%)
$46.05M(+6.5%)
Sep 2006
-
$43.23M(+13.7%)
Jun 2006
-
$38.00M(-33.2%)
Mar 2006
-
$56.89M(+40.9%)
Dec 2005
$40.37M(-42.4%)
$40.37M(-8.7%)
Sep 2005
-
$44.22M(+1.2%)
Jun 2005
-
$43.70M(-13.8%)
Mar 2005
-
$50.70M(-27.6%)
Dec 2004
$70.05M(+446.7%)
$70.05M(-7.5%)
Sep 2004
-
$75.72M(-6.8%)
Jun 2004
-
$81.27M(+436.0%)
Mar 2004
-
$15.16M(+18.3%)
Dec 2003
$12.81M(+87.2%)
$12.81M(-21.1%)
Sep 2003
-
$16.24M(+6.5%)
Jun 2003
-
$15.25M(+19.9%)
Mar 2003
-
$12.72M(+85.8%)
Dec 2002
$6.85M(-17.5%)
$6.85M(-18.0%)
Sep 2002
-
$8.35M(+8.0%)
Jun 2002
-
$7.73M(-18.1%)
Mar 2002
-
$9.44M(+13.6%)
Dec 2001
$8.30M(+20.6%)
$8.30M(+36.3%)
Sep 2001
-
$6.09M(+18.9%)
Jun 2001
-
$5.12M(+40.9%)
Mar 2001
-
$3.64M(-47.2%)
Dec 2000
$6.88M(+35.3%)
$6.88M(+90.7%)
Sep 2000
-
$3.61M(+27.7%)
Jun 2000
-
$2.83M(-39.6%)
Mar 2000
-
$4.68M(-8.0%)
Dec 1999
$5.09M(+154.4%)
$5.09M(-9.2%)
Sep 1999
-
$5.60M(-29.1%)
Jun 1999
-
$7.90M(+393.8%)
Mar 1999
-
$1.60M
Dec 1998
$2.00M
-

FAQ

  • What is BioMarin Pharmaceutical annual total current liabilities?
  • What is the all time high annual current liabilities for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual current liabilities year-on-year change?
  • What is BioMarin Pharmaceutical quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly current liabilities year-on-year change?

What is BioMarin Pharmaceutical annual total current liabilities?

The current annual current liabilities of BMRN is $606.99M

What is the all time high annual current liabilities for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual total current liabilities is $1.18B

What is BioMarin Pharmaceutical annual current liabilities year-on-year change?

Over the past year, BMRN annual total current liabilities has changed by -$570.04M (-48.43%)

What is BioMarin Pharmaceutical quarterly total current liabilities?

The current quarterly current liabilities of BMRN is $628.21M

What is the all time high quarterly current liabilities for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly total current liabilities is $1.18B

What is BioMarin Pharmaceutical quarterly current liabilities year-on-year change?

Over the past year, BMRN quarterly total current liabilities has changed by -$459.69M (-42.25%)
On this page